Ignite Creation Date:
2024-05-06 @ 4:07 PM
Last Modification Date:
2024-10-26 @ 2:04 PM
Study NCT ID:
NCT04878055
Status:
COMPLETED
Last Update Posted:
2024-06-13
First Post:
2021-04-30
Brief Title:
Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia
Sponsor:
Dompé Farmaceutici SpA
Organization:
Dompé Farmaceutici SpA